Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...

The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...

Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...

HHS has announced proposed regulations that, if finalized, would limit access to gender-affirming care in minors and ...

The FDA granted accelerated approval for sibeprenlimab-szsi to reduce proteinuria for adults with primary immunoglobulin A ...

A 63-year-old Vietnamese-speaking man with a history of scleritis in the left eye, epiretinal membrane, dry eye syndrome and ...

On the first Sunday of November, when the majority of the United States set their clocks an hour earlier, the resulting ...

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...

Goals-of-care conversations can help clinicians align treatment with patient preferences. Documenting those discussions can ...

Patients with irritable bowel syndrome could benefit from using an AI-enhanced digital collaborative care model that combines ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...